Table 2.

Standardized mortality ratios for all causes of death for men, women, and the overall cohort according to sex, age at diagnosis, age at death, time after diagnosis, and therapy.

	Men					Women					Overall
	Obs 1	Exp 2	SMR 3	95% CI 4		Obs	Exp	SMR	95% CI		Obs	Exp	SMR	95% CI
Overall	11,829	9512.57	1.24	1.22	1.27	18,371	12,849.93	1.43	1.41	1.45	30,200	22,362.50	1.35	1.34	1.37
Age at diagnosis
40–49	1216	823.09	1.48	1.40	1.56	643	284.53	2.26	2.09	2.44	1859	1107.62	1.68	1.60	1.76
50–59	3026	2416.27	1.25	1.21	1.30	2643	1456.06	1.82	1.75	1.89	5669	3872.33	1.46	1.43	1.50
60–69	4267	3452.83	1.24	1.20	1.27	6339	4070.97	1.56	1.52	1.60	10,606	7523.81	1.41	1.38	1.44
≥70	3320	2820.37	1.18	1.14	1.22	8746	7038.38	1.24	1.22	1.27	12,066	9858.75	1.22	1.20	1.25
	p < 0.001					p < 0.001					p < 0.001
Age at death
40–49	116	6.12	18.97	15.81	22.75	38	0.87	43.64	31.76	59.98	154	6.99	22.04	18.82	25.81
50–59	1112	431.17	2.58	2.43	2.74	554	116.75	4.75	4.37	5.16	1666	547.93	3.04	2.90	3.19
60–69	2858	1873.01	1.53	1.47	1.58	2197	823.51	2.67	2.56	2.78	5055	2696.52	1.87	1.82	1.93
≥70	7743	7202.27	1.08	1.05	1.10	15,582	11,908.79	1.31	1.29	1.33	23,325	19,111.07	1.22	1.20	1.24
	p < 0.001					p < 0.001					p < 0.001
Time after diagnosis *
1–5	1506	1445.09	1.04	0.99	1.10	1748	1530.28	1.14	1.09	1.20	3254	2975.37	1.09	1.06	1.13
6–10	4321	3734.52	1.16	1.12	1.19	5945	4611.66	1.29	1.26	1.32	10,266	8346.18	1.23	1.21	1.25
>10	3025	2361.79	1.28	1.24	1.33	4886	3455.61	1.41	1.37	1.45	7911	5817.40	1.36	1.33	1.39
	p < 0.001					p < 0.001					p < 0.001
Glucose-lowering drugs
Oral	9329	8252.28	1.13	1.11	1.15	14,764	11,305.37	1.31	1.29	1.33	24,093	19,557.64	1.23	1.22	1.25
Insulin and oral	1650	872.50	1.89	1.80	1.98	2624	1178.46	2.23	2.14	2.31	4274	2050.96	2.08	2.02	2.15
Insulin	850	387.79	2.19	2.05	2.34	983	366.10	2.69	2.52	2.86	1833	753.89	2.43	2.32	2.55

¹ Obs, observed; ² Exp, expected; ³ SMR, standardized mortality ratio; ⁴ CI, confidence interval; * prevalent diabetes cases at beginning of follow-up excluded from analysis.